Biliary and urinary excretion of inorganic arsenic: Monomethylarsonous acid as a major biliary metabolite in rats

被引:98
作者
Gregus, Z [1 ]
Gyurasics, A [1 ]
Csanaky, I [1 ]
机构
[1] Univ Pecs, Sch Med, Dept Pharmacol, H-7643 Pecs, Hungary
关键词
arsenic; monomethylarsonous acid; biliary excretion; methylation; urinary excretion;
D O I
10.1093/toxsci/56.1.18
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
In rats exposed to arsenite (As-III) or arsenate (AsV), the biliary excretion of arsenic depends completely on availability of hepatic glutathione, suggesting that both As-III and AsV are transported into bile in thiol-reactive trivalent form (Gyurasics et al. [1991], Biochem. Pharmacol. 42, 465-368). To test this hypothesis, the bile and urine of bile duct-cannulated rats injected with AsIII or AsV (50 mu mol/kg. iv) were collected periodically for 2 h and analyzed for arsenic metabolites by HPLC-hydride generation-atomic fluorescence spectrometry. Arsenic was excreted predominantly into bile in AsIII-injected rats, but the urine was the main route of excretion in AsV-exposed rats. Injected Asm was excreted in urine practically unchanged, whereas both AsV and AsIII appeared in urine after administration of AsV. Irrespective of the arsenical administered, the bile contained 2 main arsenic species, namely AsIII and a hitherto unidentified metabolite. Formation of this metabolite could be prevented by pretreatment of the rats with the methylation inhibitor periodate-oxidized adenosine, indicating that it is a methylated arsenic compound. This metabolite could be converted in vitro into monomethylarsonic acid (MMAsV) by oxidation, whereas synthetic MAAsV could be converted into the unknown metabolite by reduction. Consequently, this biliary metabolite of both AsIII and AsV is monomethylarsonous acid (MMAsIII), a long-hypothesized, but never identified, intermediate in the biotransformation of AsIII and AsV. Although MMAsIII is thought to be formed from an oxidized precursor, rats injected with MMAsV did not excrete MMAsIII. in summary, the inoreanic arsenicals investigated are transported into bile exclusively in trivalent forms, namely as AsIII and MMAsIII, but are excreted in urine in both tri- and pentavalent forms. Identification of MMAsIII is signified by the fact that this metabolite is more toxic than AsIII and AsV and thus formation of MMAsIII represents toxification of inorganic arsenic.
引用
收藏
页码:18 / 25
页数:8
相关论文
共 50 条
  • [21] Investigation of intestinal elimination and biliary excretion of ibuprofen in hyperglycemic rats
    Kovacs, Noemi-Piroska
    Almasi, Attila
    Garai, Kitti
    Kuzma, Monika
    Vancea, Szende
    Fischer, Emil
    Perjesi, Pal
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2019, 97 (11) : 1080 - 1089
  • [22] Effects of organic anions and vinblastine on biliary excretion of erythromycin in rats
    Sato, A
    Takikawa, H
    Yamanaka, M
    PHARMACOLOGY, 1999, 59 (05) : 249 - 256
  • [23] Effects of ursodeoxycholate and its conjugates on biliary glutathione excretion in rats
    Takikawa, H
    Sano, N
    Yamanaka, M
    DIGESTIVE DISEASES AND SCIENCES, 1996, 41 (10) : 1953 - 1958
  • [24] STEREOSELECTIVITY OF BILIARY-EXCRETION OF 2-ARYLPROPIONATES IN RATS
    MENZEL, S
    BECK, WS
    BRUNE, K
    GEISSLINGER, G
    CHIRALITY, 1993, 5 (06) : 422 - 427
  • [25] PHARMACOKINETICS, METABOLISM AND BILIARY AND URINARY-EXCRETION OF ORAL RAMIPRIL IN MAN
    VERHO, M
    LUCK, C
    STELTER, WJ
    RANGOONWALA, B
    BENDER, N
    CURRENT MEDICAL RESEARCH AND OPINION, 1995, 13 (05) : 264 - 273
  • [26] Monomethylarsonous acid, but not inorganic arsenic, is a mitochondria-specific toxicant in vascular smooth muscle cells
    Pace, Clare
    Das Banerjee, Tania
    Welch, Barrett
    Khalili, Roxana
    Dagda, Ruben K.
    Angermann, Jeff
    TOXICOLOGY IN VITRO, 2016, 35 : 188 - 201
  • [27] Association of dietary intake and urinary excretion of inorganic arsenic in the Japanese subjects
    Yoshinaga, Jun
    Narukawa, Tomohiro
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2020, 116
  • [28] BILIARY-EXCRETION OF CHENODEOXYCHOLYLLYSYLRHODAMINE IN WISTAR RATS - A POSSIBLE ROLE OF A BILE-ACID AS A CARRIER FOR DRUGS
    MILLS, CO
    ELIAS, E
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1126 (01) : 35 - 40
  • [29] Dosing-time-dependent variation in biliary excretion of flomoxef in rats
    Hishikawa, S
    Sugimoto, K
    Kobayashi, E
    Kumagai, Y
    Fujimura, A
    CHRONOBIOLOGY INTERNATIONAL, 2003, 20 (03) : 463 - 471
  • [30] Uptake by hepatocytes and biliary excretion of intravenously administered polystyrene microspheres in rats
    Ogawara, K
    Yoshida, M
    Furumoto, K
    Takakura, Y
    Hashida, M
    Higaki, K
    Kimura, T
    JOURNAL OF DRUG TARGETING, 1999, 7 (03) : 213 - +